APA aipamena

Green, A. R., Barros, F. F. T., Abdel-Fatah, T. M. A., Moseley, P., Nolan, C. C., Durham, A. C., . . . Ellis, I. O. (2014). HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer. Springer US.

Chicago Style aipamena

Green, Andrew R., Fabrício F. T. Barros, Tarek M. A. Abdel-Fatah, Paul Moseley, Christopher C. Nolan, Alice C. Durham, Emad A. Rakha, Stephen Chan, and Ian O. Ellis. HER2/HER3 Heterodimers and P21 Expression Are Capable of Predicting Adjuvant Trastuzumab Response in HER2+ Breast Cancer. Springer US, 2014.

MLA aipamena

Green, Andrew R., et al. HER2/HER3 Heterodimers and P21 Expression Are Capable of Predicting Adjuvant Trastuzumab Response in HER2+ Breast Cancer. Springer US, 2014.